Oryzon Genomics SA (ORYZF)
3.65
+0.31
(+9.28%)
USD |
OTCM |
May 19, 16:00
Oryzon Genomics Total Assets (Quarterly) : 162.93M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Grifols SA | 23.13B |
| Pharma Mar SA | 443.90M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Agenus, Inc. | 186.46M |
| Alkermes Plc | 4.258B |
Total Assets (Quarterly) Related Metrics
| Shareholders Equity (Quarterly) | 136.01M |
| Current Ratio | 1.945 |
| Net Debt Paydown Yield | 1.29% |